Welcome to the ASPIRE Project!
Who we are
The ASPIRE Consortium is an African-European collaborative network supported by the Global Health European & Developing Countries Clinical Trials Partnership 3 (Global Health EDCTP3) conducting research projects in Ghana and Ethiopia. The focus of the ASPIRE Consortium is antimicrobial resistance (AMR) characterization and surveillance, hospital hygiene and infection prevention and control (IPC), antibiotic stewardship (ASP) support, and identification of novel and adapted interventions in the fight against AMR. Combining expertise in clinical infectious disease, microbiology, infection prevention and control, health economics and eHealth systems, we cover a broad and multi-disciplinary range to design, support and conduct implementation research in African countries.
Missions and Goals
An estimated 5 million deaths worldwide were associated with bacterial antimicrobial resistance (AMR) in 2019. AMR rates are particularly high in African countries.
Project
ASPIRE, funded by EDCTP, targets to optimize antimicrobial stewardship (AMS) through drug resistance information and therapeutic drug monitoring (TDM).
Consortium
This study will be performed by a consortium of inter-disciplinary African and European experts from Ghana, Ethiopia, Germany, Norway, and partners in India.
News
Fotos: Freepik / wirestock; jcomb; matteoguedia; Alla541; Wavebreak Media